Results 201 to 210 of about 6,944 (246)

Factors influencing the selection of an SGLT2i vs. a GLP-1RA as cardioprotective agent in patients with type 2 diabetes. [PDF]

Front Cardiovasc Med
Agarwal S, Basit MA, Bowen ME, Heitjan DF, Mai C, Marble K, Pak J, Xiang Z, Lingvay I.   +8 more
europepmc   +1 more source

GLP-1RA Promotes Beige Differentiation in Adipose Tissue

Advances in Clinical Medicine
openaire   +1 more source

Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes. [PDF]

Cardiovasc Diabetol
Chaiyakunapruk N, Tan X, Liang Y, Guevarra M, Xie L, Cheng AYY.   +5 more
europepmc   +1 more source

Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trial. [PDF]

Am J Prev Cardiol
Nelson AJ, Kaltenbach LA, Al-Khalidi HR, Leyva M, Webb L, McGuire DK, Pop-Busui R, Cavender MA, Aroda VR, Magwire ML, Richardson CR, Lingvay I, Kirk JK, Pandey A, Gaynor T, Pak J, Washington A, Senyucel C, Lopes RD, Green JB, Granger CB, Pagidipati NJ.   +21 more
europepmc   +1 more source

Relative contribution of different effects to overall improvement in disability-adjusted life years (DALYs) with GLP-1RA and SGLT2-i therapy.

Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC (21144089)
openalex   +1 more source

Secondary stroke prevention beyond antiplatelets: The role of colchicine and GLP-1RA - an ounce of prevention is worth a pound of cure. [PDF]

Ther Adv Neurol Disord
Mijajlović MD, Bornstein NM, Aleksić V.   +2 more
europepmc   +1 more source

GLP-1RA may open a new era for MASLD treatment

Clinical and Molecular Hepatology
Ye Feng, Chengfu Xu
openaire   +1 more source

GLP-1RA improves diabetic renal injury by alleviating glomerular endothelial cells pyrotosis via RXRα/circ8411/miR-23a-5p/ABCA1 pathway

Weixi Wu, Yao Wang, Xian Shao, Shuai Huang, Jian Wang, Saijun Zhou, Hongyan Liu, Yao Lin, Pei Yu   +8 more
openalex   +1 more source

GLP-1RA-induced delays in gastrointestinal motility: Predicted effects on coadministered drug absorption by PBPK analysis. [PDF]

Pharmacotherapy
Hooper L, Liu S, Pai MP.
europepmc   +1 more source

The Effect of Frailty on Body Composition and Its Impact on the Use of SGLT-2 Inhibitors and GLP-1RA in Older Persons with Diabetes. [PDF]

Metabolites
Sinclair A, Siqueira I, Abdelhafiz A.
europepmc   +1 more source